Empagliflozin as a new management strategy on outcomes in patients with type 2 diabetes mellitus

Patients with type 2 diabetes mellitus have an increased risk of cardiovascular (CV) complications. Although hyperglycaemia contributes to the pathogenesis of atherosclerosis and heart failure in these patients, glucose-lowering strategies did not have a significant effect on reducing CV risk, parti...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Vladimir V. Salukhov, Tatiana Y. Demidova
Formato: article
Lenguaje:EN
RU
Publicado: Endocrinology Research Centre 2016
Materias:
Acceso en línea:https://doaj.org/article/df96db84249147979cbed089b1755da3
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!